Autocrine regulation of IL-21 production in human T lymphocytes

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1800-1807

  Caprioli, Flavio ^a   Sarra, Massimiliano ^a   Caruso, Roberta ^a   Stolfi, Carmine ^a   Fina, Daniele ^a   Sica, Giuseppe ^a   MacDonald, Thomas T ^b   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; PROTEIN SUBUNIT; RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; CD3 ANTIGEN; CYTOKINE; INTERLEUKIN DERIVATIVE; STAT3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CD3+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; INTESTINE CELL; LAMINA PROPRIA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; T LYMPHOCYTE; DRUG ANTAGONISM; DRUG EFFECT; ENTERITIS; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; MUCOSA; RNA INTERFERENCE;

ANTIGENS, CD3; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; INTESTINES; MUCOUS MEMBRANE; PROMOTER REGIONS (GENETICS); RNA INTERFERENCE; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 40749123066     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1800     Document Type: Article

References (45)

1. McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7: 429-442.
2. Kay, A. B. 2006. The role of T lymphocytes in asthma. Chem. Immunol. Allergy 91: 59-75.
3. Papadakis, K. A., and S. R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298.
4. Liu, E. H., R. M. Siegel, D. M. Harlan, and J. J. O'Shea. 2007. T cell-directed therapies: lessons learned and future prospects. Nat. Immunol. 8: 25-30.
5. Pizarro, T. T., and F. Cominelli. 2007. Cytokine therapy for Crohn's disease: advances in translational research. Annu. Rev. Med. 58: 433-444.
6. Baumgart, D. C., and W. J. Sandborn. 2007. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
7. Feldmann, M. 2002. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2: 364-371.
8. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
9. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
10. + T cells that respond to bacterial antigens. J. Immunol. 162: 1884-1888.
11. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis, and differentiation. Nat. Rev. Immunol. 5: 688-698.
12. Mehta, D. S., A. L. Wurster, and M. J. Grusby. 2004. Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95.
13. Ostiguy, V., E. L. Allard, M. Marquis, J. Leignadier, and N. Labrecque. 2007. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J. Leukocyte Biol. 82: 645-656.
14. + T lymphocytes. J. Immunol. 178: 732-739.
15. Kasaian, M. T., M. J. Whitters, L. L. Carter, L. D. Lowe, J. M. Jussif, B. Deng, K. A. Johnson, J. S. Witek, M. Senices, R. F. Konz, et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569.
16. Strengell, M., T. Sareneva, D. Foster, I. Julkunen, and S. Matikainen. 2002. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169: 3600-3605.
17. Strengell, M., S. Matikainen, J. Siren, A. Lehtonen, D. Foster, I. Julkunen, and T. Sareneva. 2003. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170: 5464-5469.
18. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, III, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
19. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
20. Monteleone, G., I. Monteleone, D. Fina, P. Vavassori, G. Del Vecchio Blanco, R. Caruso, R. Tersigni, L. Alessandroni, L. Biancone, G. C. Naccari, et al. 2005. Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn's disease. Gastroenterology 128: 687-694.
21. Van Heel, D. A., L. Franke, K. A. Hunt, R. Gwilliam, A. Zhernakova, M. Inouye, M. C. Wapenaar, M. C. Barnardo, G. Bethel, G. K. Holmes, et al. 2007. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39: 827-829.
22. Caruso, R., D. Fina, I. Peluso, M. C. Fantini, C. Tosti, G. Del Vecchio Blanco, O. A. Paoluzi, F. Caprioli, F. Andrei, C. Stolfi, et al. 2007. IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178: 5957-5965.
23. Caruso, R., D. Fina, I. Peluso, C. Stolfi, M. C. Fantini, V. Gioia, F. Caprioli, G. Del Vecchio Blanco, O. A. Paoluzi, T. T. Macdonald, et al. 2007. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3β, by gut epithelial cells. Gastroenterology 132: 166-175.
24. Monteleone, G., R. Caruso, D. Fina, I. Peluso, V. Gioia, C. Stolfi, M. C. Fantini, F. Caprioli, R. Tersigni, L. Alessandroni, et al. 2006. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55: 1774-1780.
25. Herber, D., T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830.
26. Young, D. A., M. Hegen, H. L. Ma, M. J. Whitters, L. M. Albert, L. Lowe, M. Senices, P. W. Wu, B. Sibley, Y. Leathurby, et al. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56: 1152-1163.
27. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167: 1-5.
28. Parrish-Novak, J., D. C. Foster, R. D. Holly, and C. H. Clegg. 2002. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukocyte Biol. 72: 856-863.
29. Habib, T., S. Senadheera, K. Weinberg, and K. Kaushansky. 2002. The common γ-chain (γ c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41: 8725-8731.
30. Ozaki, K., K. Kikly, D. Michalovich, P. R. Young, and W. J. Leonard. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor β-chain. Proc. Natl. Acad. Sci. USA 97: 11439-11444.
31. Monteleone, G., L. Biancone, R. Marasco, G. Morrone, O. Marasco, F. Luzza, and F. Pallone. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112: 1169-1178.
32. Strengell, M., I. Julkunen, and S. Matikainen. 2004. IFN-α regulates IL-21 and IL-21R expression in human NK and T cells. J. Leukocyte Biol. 76: 416-422.
33. + T cell expansion and function. J. Exp. Med. 201: 139-148.
34. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
35. Zeng, R., R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard. 2007. The molecular basis of IL-21-mediated proliferation. Blood 109: 4135-4142.
36. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
37. Ina, K., J. Itoh, K. Fukushima, K. Kusugami, T. Yamaguchi, K. Kyokane, A. Imada, D. G. Binion, A. Musso, G. A. West, et al. 1999. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 163: 1081-1090.
38. Boirivant, M., M. Marini, G. Di Felice, A. M. Pronio, C. Montesani, R. Tersigni, and W. Strober. 1999. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 116: 557-565.
39. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat. Med. 6: 583-588.
40. King, C., A. Ilic, K. Koelsch, and N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265-277.
41. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
42. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
43. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
44. Wurster, A. L., V. L. Rodgers, A. R. Satoskar, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2002. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med. 196: 969-977.
45. Suto, A., A. L. Wurster, S. L. Reiner, and M. J. Grusby. 2006. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 177: 3721-3727.